Read the publication to explore:
-
The role of High Content Screening (HCS) with iPSC-derived neurons as New Approach Methodologies (NAMs) supporting FDA and NIH initiatives
-
The impact of automation and machine learning on making phenotypic screening scalable and statistically robust for drug discovery
-
Sample protocols and a comprehensive review of the advantages, challenges, and pitfalls of neuronal screening
- How ioGlutamatergic Neurons were used
Markossian S, Grossman A, Baskir H, et al.
Assay Guidance Manual. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences.
2024-2025